<DOC>
	<DOC>NCT00723216</DOC>
	<brief_summary>The primary objective of this study is to evaluate the effects of enoxaparin on venous thromboembolism incidence and bleeding rate (major and minor bleeding) in patients undergoing curative abdominal cancer surgery. The secondary objective is evaluate the incidence of adverse events of enoxaparin in these patients.</brief_summary>
	<brief_title>Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Abdominal Neoplasms</mesh_term>
	<criteria>Malignant tumor patients undergoing laparotomy for which surgery is expected to take 45 minutes or more. surgery under laparoscope and other endoscopic operations clinical signs of deep vein thrombosis use of nonsteroidal antiinflammatory drugs from surgery completion until initial administration severe hepatic disease or renal disease women of childbearing potential, pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Prevention</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>curative surgery</keyword>
</DOC>